Quent Capital LLC Grows Holdings in Humana Inc. (NYSE:HUM)

Quent Capital LLC raised its position in Humana Inc. (NYSE:HUM) by 47.1% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 300 shares of the insurance provider’s stock after purchasing an additional 96 shares during the period. Quent Capital LLC’s holdings in Humana were worth $112,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in Humana during the 4th quarter worth approximately $676,800,000. Sanders Capital LLC acquired a new stake in Humana during the 4th quarter worth approximately $489,300,000. Ontario Teachers Pension Plan Board increased its position in Humana by 11,647.2% during the 1st quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock worth $367,342,000 after purchasing an additional 1,050,459 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Humana by 0.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 984,618 shares of the insurance provider’s stock worth $450,749,000 after purchasing an additional 8,164 shares in the last quarter. Finally, Janus Henderson Group PLC increased its position in Humana by 47.4% during the 1st quarter. Janus Henderson Group PLC now owns 975,097 shares of the insurance provider’s stock worth $338,026,000 after purchasing an additional 313,530 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on HUM shares. Jefferies Financial Group dropped their target price on shares of Humana from $411.00 to $381.00 and set a “buy” rating for the company in a research report on Monday, April 22nd. Piper Sandler assumed coverage on shares of Humana in a research report on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 price objective for the company. Baird R W raised shares of Humana to a “hold” rating in a research report on Thursday, May 30th. Morgan Stanley assumed coverage on shares of Humana in a research report on Monday, June 24th. They issued an “equal weight” rating and a $374.00 price objective for the company. Finally, Oppenheimer increased their price objective on shares of Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a research report on Thursday, August 1st. Fourteen research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $403.55.

Humana Stock Down 0.3 %

Shares of Humana stock traded down $0.97 on Tuesday, hitting $355.32. 930,729 shares of the company’s stock traded hands, compared to its average volume of 1,739,943. The stock has a market cap of $42.78 billion, a P/E ratio of 22.12, a PEG ratio of 2.09 and a beta of 0.51. The company has a quick ratio of 1.67, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. The firm’s 50-day moving average is $368.04 and its 200 day moving average is $347.41. Humana Inc. has a 52-week low of $298.61 and a 52-week high of $530.54.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The firm had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. During the same period last year, the business posted $8.94 earnings per share. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. Equities analysts anticipate that Humana Inc. will post 16.14 earnings per share for the current year.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.